Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 5/2006

01.05.2006 | Article

Clinical features and outcome of spontaneous bacterial peritonitis in HIV-infected cirrhotic patients: a case-control study

verfasst von: E. Shaw, J. Castellote, M. Santín, X. Xiol, G. Euba, C. Gudiol, C. Lopez, X. Ariza, F. Gudiol

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate the clinical characteristics and outcome of spontaneous bacterial peritonitis, a serious complication in patients with cirrhosis and ascites, in an HIV-infected cirrhotic population. Thirty-five HIV-infected cirrhotic patients who developed spontaneous bacterial peritonitis during a 12-year period were compared with 70 non-HIV-infected cirrhotic subjects. Patients were matched according to the date of the first episode of spontaneous bacterial peritonitis. A bacteriological diagnosis was made in 37 of 47 (79%) and in 50 of 97 (52%) episodes in the HIV group and in the non-HIV group, respectively (p=0.003), and Streptococcus pneumoniae was isolated more frequently in the HIV group (22 vs. 8%, p=0.02). Median survival after the initial diagnosis of spontaneous bacterial peritonitis was 2.9 and 14.0 months in the HIV group and non-HIV group, respectively. Age (hazard ratio [HR] 1.04; 95%CI 1.01–1.07), male sex (HR 2.55; 95%CI 1.34–4.83), Child–Pugh score at first spontaneous bacterial peritonitis episode (HR 1.29; 95%CI 1.10–1.54), renal impairment at first spontaneous bacterial peritonitis episode (HR 2.61; 95%CI 1.49–4.62), and HIV infection (HR 9.81; 95%CI 4.03–23.84) were independently associated with higher long-term mortality after the first diagnosis of spontaneous bacterial peritonitis. In conclusion, HIV-infected cirrhotic patients with spontaneous bacterial peritonitis have a higher rate of bacteriological diagnosis and a more frequent pneumococcal etiology than non-HIV-infected subjects. Life expectancy in these patients, once spontaneous bacterial peritonitis has developed, is poor. These data are particularly relevant for determining the optimal time for liver transplantation in this population.
Literatur
1.
Zurück zum Zitat Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338:853–860PubMedCrossRef Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338:853–860PubMedCrossRef
2.
Zurück zum Zitat Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d’Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 352:1725–1730PubMedCrossRef Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d’Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 352:1725–1730PubMedCrossRef
3.
Zurück zum Zitat Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, Chiesi A, Phillips AN, Kirk O, Lundgren JD (2000) AIDS across Europe, 1994–98: the EuroSIDA study. Lancet 356:291–296PubMedCrossRef Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, Chiesi A, Phillips AN, Kirk O, Lundgren JD (2000) AIDS across Europe, 1994–98: the EuroSIDA study. Lancet 356:291–296PubMedCrossRef
4.
Zurück zum Zitat Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK (2002) Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994–1998. J Infect Dis 186:1023–1027PubMedCrossRef Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK (2002) Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994–1998. J Infect Dis 186:1023–1027PubMedCrossRef
5.
Zurück zum Zitat Soriano V, Garcia-Samaniego J, Valencia E, Rodríguez-Rosado R, Munoz F, Gonzalez-Lahoz J (1999) Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users. Eur J Epidemiol 15:1–4PubMedCrossRef Soriano V, Garcia-Samaniego J, Valencia E, Rodríguez-Rosado R, Munoz F, Gonzalez-Lahoz J (1999) Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users. Eur J Epidemiol 15:1–4PubMedCrossRef
6.
Zurück zum Zitat Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR (2001) Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 32:492–497PubMedCrossRef Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR (2001) Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 32:492–497PubMedCrossRef
7.
Zurück zum Zitat Rosenthal E, Poiree M, Pradier C, Perronne C, Salmon-Ceron D, Geffray L, Myers RP, Morlat P, Pialoux G, Pol S, Cacoub P, and the GERMIVIC Joint Study Group (2003) Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 17:1803–1809PubMedCrossRef Rosenthal E, Poiree M, Pradier C, Perronne C, Salmon-Ceron D, Geffray L, Myers RP, Morlat P, Pialoux G, Pol S, Cacoub P, and the GERMIVIC Joint Study Group (2003) Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 17:1803–1809PubMedCrossRef
8.
Zurück zum Zitat Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutallier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T (1999) Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 30:1054–1058PubMedCrossRef Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutallier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T (1999) Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 30:1054–1058PubMedCrossRef
9.
Zurück zum Zitat Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P (2001) The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 34:1193–1199PubMedCrossRef Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P (2001) The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 34:1193–1199PubMedCrossRef
10.
Zurück zum Zitat Martín-Carbonero L, Benhamou Y, Puoti M, Berenguer J, Mallolas J, Quereda C, Arizcorreta A, Gonzalez A, Rockstroh J, Asensi V, Miralles P, Laguno M, Moreno L, Giron JA, Vogel M, Garcia-Samaniego J, Nuñez M, Romero M, Moreno S, de la Cruz JJ, Soriano V (2004) Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study. Clin Infect Dis 38:128–133PubMedCrossRef Martín-Carbonero L, Benhamou Y, Puoti M, Berenguer J, Mallolas J, Quereda C, Arizcorreta A, Gonzalez A, Rockstroh J, Asensi V, Miralles P, Laguno M, Moreno L, Giron JA, Vogel M, Garcia-Samaniego J, Nuñez M, Romero M, Moreno S, de la Cruz JJ, Soriano V (2004) Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study. Clin Infect Dis 38:128–133PubMedCrossRef
11.
Zurück zum Zitat Roland ME, Adey D, Laurie L, Carlson MS, Terrault NA (2003) Kidney and liver transplantation in HIV-infected patients: case presentations and review. AIDS Patient Care STDS 17:501–507PubMedCrossRef Roland ME, Adey D, Laurie L, Carlson MS, Terrault NA (2003) Kidney and liver transplantation in HIV-infected patients: case presentations and review. AIDS Patient Care STDS 17:501–507PubMedCrossRef
12.
Zurück zum Zitat Von Wichmann MA, Arevalo S, Zapata E, Rodriguez Arrondo F, Arrizabalaga J, Iribarren JA, Camino X, Garcia Bengoechea M, Txoperena G (2003) Survival in HIV+ patients with viral hepatitis after ascites has developed. In: Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract no. V-782 Von Wichmann MA, Arevalo S, Zapata E, Rodriguez Arrondo F, Arrizabalaga J, Iribarren JA, Camino X, Garcia Bengoechea M, Txoperena G (2003) Survival in HIV+ patients with viral hepatitis after ascites has developed. In: Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract no. V-782
13.
Zurück zum Zitat Toledo C, Salmerón JM, Rimola A, Navasa M, Arroyo V, Llach J, Gines A, Gines P, Rodes J (1993) Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 17:251–257PubMed Toledo C, Salmerón JM, Rimola A, Navasa M, Arroyo V, Llach J, Gines A, Gines P, Rodes J (1993) Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 17:251–257PubMed
14.
Zurück zum Zitat Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, Gassull MA, Arroyo V, Rodes J (1994) Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 20:1495–1501PubMedCrossRef Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, Gassull MA, Arroyo V, Rodes J (1994) Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 20:1495–1501PubMedCrossRef
15.
16.
Zurück zum Zitat Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341:403–409PubMedCrossRef Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341:403–409PubMedCrossRef
17.
Zurück zum Zitat Thuluvath PJ, Morss S, Thompson R (2001) Spontaneous bacterial peritonitis: in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol 96:1232–1236PubMed Thuluvath PJ, Morss S, Thompson R (2001) Spontaneous bacterial peritonitis: in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol 96:1232–1236PubMed
18.
Zurück zum Zitat Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J. Hepatology 32:142–153CrossRef Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J. Hepatology 32:142–153CrossRef
19.
Zurück zum Zitat Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Scholmeich J (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 23:164–176PubMedCrossRef Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Scholmeich J (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 23:164–176PubMedCrossRef
20.
Zurück zum Zitat Centers for Disease Control and Prevention (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41 (no. RR-17) Centers for Disease Control and Prevention (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41 (no. RR-17)
21.
Zurück zum Zitat Castellote J, Xiol X, Verdaguer R, Ribes J, Guardiola J, Gimenez A, Casais L (1990) Comparison of two ascitic fluid culture methods in cirrhotic patients with spontaneous bacterial peritonitis. Am J Gastroenterol 85:1605–1608PubMed Castellote J, Xiol X, Verdaguer R, Ribes J, Guardiola J, Gimenez A, Casais L (1990) Comparison of two ascitic fluid culture methods in cirrhotic patients with spontaneous bacterial peritonitis. Am J Gastroenterol 85:1605–1608PubMed
22.
Zurück zum Zitat Runyon B, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA (1991) Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. Gastroenterology 100:1737–1742PubMed Runyon B, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA (1991) Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. Gastroenterology 100:1737–1742PubMed
23.
Zurück zum Zitat Llovet JM, Planas R, Morillas R, Quer JC, Cabre E, Boix J, Humbert P, Guilera M, Domenech E, Bertran X, Gassull MA (1993) Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol 88:388–392PubMed Llovet JM, Planas R, Morillas R, Quer JC, Cabre E, Boix J, Humbert P, Guilera M, Domenech E, Bertran X, Gassull MA (1993) Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol 88:388–392PubMed
24.
Zurück zum Zitat Redd SC, Rutherford GW, Sande MA, Lifson AR, Hadley WK, Facklam RR, Spika JS (1990) The role of human immunodeficiency virus infection in pneumococcal bacteriemia in San Francisco residents. J Infect Dis 162:1012–1017PubMed Redd SC, Rutherford GW, Sande MA, Lifson AR, Hadley WK, Facklam RR, Spika JS (1990) The role of human immunodeficiency virus infection in pneumococcal bacteriemia in San Francisco residents. J Infect Dis 162:1012–1017PubMed
25.
Zurück zum Zitat Centers for Disease Control and Prevention (1989) Recommendations of the Immunization Practices Advisory Committee on Pneumococcal Polysaccharide Vaccine. MMWR Morb Mortal Wkly Rep 38:64–68, 73–76 Centers for Disease Control and Prevention (1989) Recommendations of the Immunization Practices Advisory Committee on Pneumococcal Polysaccharide Vaccine. MMWR Morb Mortal Wkly Rep 38:64–68, 73–76
26.
Zurück zum Zitat Singh N, Wagener MM, Gayowski T (2003) Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit. Clin Microbiol Infect 9:531–537PubMedCrossRef Singh N, Wagener MM, Gayowski T (2003) Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit. Clin Microbiol Infect 9:531–537PubMedCrossRef
27.
Zurück zum Zitat Campillo B, Richardet JP, Kheo T, Dupeyron C (2002) Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis 35:1–10PubMedCrossRef Campillo B, Richardet JP, Kheo T, Dupeyron C (2002) Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis 35:1–10PubMedCrossRef
28.
Zurück zum Zitat Capdevila O, Pallares R, Grau I, Tubau F, Linares J, Ariza J, Gudiol F (2001) Pneumococcal peritonitis in adult patients. Arch Intern Med 161:1742–1748PubMedCrossRef Capdevila O, Pallares R, Grau I, Tubau F, Linares J, Ariza J, Gudiol F (2001) Pneumococcal peritonitis in adult patients. Arch Intern Med 161:1742–1748PubMedCrossRef
29.
Zurück zum Zitat Winston JA, Bruggeman LA, Ross MD, Jacobson J, Ross L, D’Agati VD, Klotman PE, Klotman ME (2001) Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344:1979–1984PubMedCrossRef Winston JA, Bruggeman LA, Ross MD, Jacobson J, Ross L, D’Agati VD, Klotman PE, Klotman ME (2001) Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344:1979–1984PubMedCrossRef
31.
Zurück zum Zitat Navasa M, Follo A, Filella X, Jimenez W, Francitorra A, Planas R, Rimola A, Arroyo V, Rodes J (1998 ) Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 27:1227–1232PubMedCrossRef Navasa M, Follo A, Filella X, Jimenez W, Francitorra A, Planas R, Rimola A, Arroyo V, Rodes J (1998 ) Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 27:1227–1232PubMedCrossRef
32.
Zurück zum Zitat Ruiz-del-Arbol L, Urman J, Fernandez J, Gonzalez M, Navasa M, Monescillo A, Albillos A, Jimenez W, Arroyo V (2003) Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 38:1210–1218PubMedCrossRef Ruiz-del-Arbol L, Urman J, Fernandez J, Gonzalez M, Navasa M, Monescillo A, Albillos A, Jimenez W, Arroyo V (2003) Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 38:1210–1218PubMedCrossRef
33.
Zurück zum Zitat Gougeon ML, Ledru E, Naora H, Bocchino M, Lecoeur H (2000) HIV, cytokines and programmed cell death. A subtle interplay. Ann N Y Acad Sci 926:30–45PubMedCrossRef Gougeon ML, Ledru E, Naora H, Bocchino M, Lecoeur H (2000) HIV, cytokines and programmed cell death. A subtle interplay. Ann N Y Acad Sci 926:30–45PubMedCrossRef
34.
Zurück zum Zitat Kedzierska K, Crowe SM (2001) Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother 12:133–150PubMed Kedzierska K, Crowe SM (2001) Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother 12:133–150PubMed
35.
Zurück zum Zitat Fantuzzi L, Belardelli F, Gessani S (2003) Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis. J Leukoc Biol 74:719–725PubMedCrossRef Fantuzzi L, Belardelli F, Gessani S (2003) Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis. J Leukoc Biol 74:719–725PubMedCrossRef
36.
Zurück zum Zitat Guarner C, Solà R, Soriano G, Andreu M, Novella MT, Vila MC, Sabat M, Coll S, Ortiz J, Gomez C, Balanzo J (1999) Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 117:414–419PubMedCrossRef Guarner C, Solà R, Soriano G, Andreu M, Novella MT, Vila MC, Sabat M, Coll S, Ortiz J, Gomez C, Balanzo J (1999) Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 117:414–419PubMedCrossRef
37.
Zurück zum Zitat Rimola A, Salmeron JM, Clemente G, Rodrigo L, Obrador A, Miranda ML, Guarner C, Planas R, Sola R, Vargas V, Casafont F, Marco F, Bañares R, Arroyo V, Rodes J (1995) Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 21:674–679PubMed Rimola A, Salmeron JM, Clemente G, Rodrigo L, Obrador A, Miranda ML, Guarner C, Planas R, Sola R, Vargas V, Casafont F, Marco F, Bañares R, Arroyo V, Rodes J (1995) Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 21:674–679PubMed
Metadaten
Titel
Clinical features and outcome of spontaneous bacterial peritonitis in HIV-infected cirrhotic patients: a case-control study
verfasst von
E. Shaw
J. Castellote
M. Santín
X. Xiol
G. Euba
C. Gudiol
C. Lopez
X. Ariza
F. Gudiol
Publikationsdatum
01.05.2006
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 5/2006
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-006-0136-9

Weitere Artikel der Ausgabe 5/2006

European Journal of Clinical Microbiology & Infectious Diseases 5/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.